HomeENZ • NYSE
Enzo Biochem Inc
Follow
$0.29
0.28%
Pre-market:(2.17%)+0.0063
$0.30
Closed: Apr 8, 4:05:00 AM GMT-4 · USD · NYSE · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Revenue | 7.33M | -14.25% |
Operating expense | 5.39M | -15.95% |
Net income | -1.54M | 49.85% |
Net profit margin | -20.93 | 41.52% |
Earnings per share | — | — |
EBITDA | -1.28M | 33.06% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 40.30M | -33.11% |
Total assets | 67.51M | -31.86% |
Total liabilities | 20.89M | -26.17% |
Total equity | 46.62M | — |
Shares outstanding | 52.40M | — |
Price to book | 0.33 | — |
Return on assets | -5.61% | — |
Return on capital | -7.96% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Net income | -1.54M | 49.85% |
Cash from operations | -2.03M | 77.33% |
Cash from investing | -70.00K | -180.00% |
Cash from financing | -5.32M | -24,100.00% |
Net change in cash | -7.44M | 17.04% |
Free cash flow | -6.77M | -2.32% |
Previous close
$0.29
Day range
$0.26 - $0.33
Year range
$0.25 - $1.28
Market cap
15.24M USD
Avg Volume
184.85K
P/E ratio
-
Dividend yield
34.39%
Primary exchange
NYSE
About
Founded
1976
Website
Employees
131